The “EMERGE” study, aimed to capture real-life management patterns and outcomes in metastatic breast cancer (MBC) in Greece, also accounting for hormone (HR) and human epidermal growth factor receptor 2 (HER2) status. | Epidemiological characteristics clinical outcomes and management patterns of metastatic breast cancer patients in routine clinical care settings of Greece Results from the EMERGE multicenter retrospective chart review study